More spinal fusions are taking place each year, with >470,000 fusion procedures in top 5 EU territories.
But pseudarthrosis/non-union rates have not improved enough in the past 20 years to reduce the overall number of revision cases:
the current % rate of non-unions
the current % rate of revisions
According to published research from spine surgeons, which of the following is the most effective way to improve spinal fusion rates? Please select one of the answers below.
0% improvement in fusion outcomes following 35-40 procedures of learning curve under controlled conditions.9
6% incremental gain in fusion outcomes with a new and improved approach and/or hardware system.10
Using the most effective bone graft can improve fusion outcomes by up to 60%.2,10,11
From pre-clinical studies to real-world evidence.
In 2018, Dr. Kees Poelstra performed an investigator-led, retrospective cohort study using MagnetOs in 52 cases of lumbar interbody spinal fusion, to evaluate its efficacy in a real-world patient population.41
MagnetOs isn’t like any other synthetic bone graft. It’s osteoinductive thanks to our unique NeedleGrip™ surface technology which provides traction for our body’s vitally important ‘pro-healing’ immune cells (M2 macrophages).*42
This in turn, unlocks previously untapped potential to stimulate stem cells - and form new bone throughout the graft.7,14,43
The growing body of science behind NeedleGrip is called osteoimmunology. But for surgeons and their patients it means one thing: a more efficient and predictable fusion.*
Contact us to:
*MagnetOs has been proven to generate more predictable fusions than two commercially available alternatives in an ovine model of posterolateral fusion. Results from in vivo laboratory testing may not be predictive of clinical experience in humans. For important safety and intended use information please refer to the Instructions for Use for a full list of indications, contraindications, precautions, and warnings.
MagnetOs and NeedleGrip are trademarks of Kuros Biosciences. Actifuse is a registered trademark of Baxter International Inc. Allovance is a registered trademark of Australian Biotechnologies Pty Ltd. Attrax is a trademark of NuVasive Inc. Bonalive is a trademark of Bonalive Biomaterials Ltd. Fibergraft is a registered trademark of Prosidyan, Inc. i-FACTOR is a trademark of Cerapedics, Inc. Novabone is a trademark of NovaBone Products, LLC. Vitoss is a trademark of Orthovita, Inc. ViviGen is a registered trademark of LifeNet Health. Osteoset is a trademark of Wright Medical Group N.V. Nanobone is a trademark of Artoss GmbH. Mastergraft, InductOs and Infuse are trademarks of Medtronic Plc. Pro-osteon is a trademark of Interpore International. Chronos is a registered trademark of DePuy Synthes Companies. Fibergraft is a registered trademark of Prosidyan, Inc. DBX is a registered trademark of MTF. Grafton DBM is a trademark of Osteotech, Inc.
PROMO_MAG_EU_063-21 Aug '21